Transcriptional and translational regulation of glutamate receptor expressi
on determines one of the key phenotypic features of neurons in the brain-th
e properties of their excitatory synaptic receptors. Up- and down-regulatio
n of various glutamate receptor subunits occur throughout development, foll
owing ischemia, seizures, repetitive activation of afferents, or chronic ad
ministration of a variety of drugs. The promoters of the genes that encode
the NR1, NR2B, NR2C, GluR1, GluR2, and KA2 subunits share several character
istics that include multiple transcriptional start sites within a CpG islan
d, lack of TATA and CAAT boxes, and neuronal-selective expression. In most
cases, the promoter regions include overlapping Sp1 and GSG motifs near the
major initiation sites, and a silencer element, to guide expression in neu
rons. Manipulating the levels of glutamate receptors in vivo by generating
transgenic and knockout mice has enhanced understanding of the role of spec
ific glutamate receptor subunits in long-term potentiation and depression,
learning, seizures, neural pattern formation, and survival. Neuron-specific
glutamate receptor promoter fragments may be employed in the design of nov
el gene-targeting constructs to deliver future experimental transgene and t
herapeutic agents to selected neurons in the brain.